CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Advertisement

Nipro April 2026

Syringe Siliconisation: Trends, Methods, Analysis Procedures

Ready-to-fill, i.e. sterile, prefillable glass syringes, are washed, siliconised, sterilised and packaged by the primary packaging manufacturer. They can then be filled by pharmaceutical companies without any further processing.These days the majority of prefillable syringes are made of glass, and the trend looks set to continue. The siliconisation of the syringe barrel is an extremely important aspect of the production of sterile, prefillable glass syringes because the functional interaction of the glass barrel siliconisation and the plunger stopper siliconisation is crucial to the efficiency of the entire system. Both inadequate and excessive siliconisation can cause problems in this connection.  Bruno Reuter & Claudia Petersen at Gerresheimer Bünde explain how, with the use of modern technology, we can achieve an extremely uniform distribution of silicone oil in glass syringes with reduced quantities of silicone oil.

https://international-pharma.com/wp-content/uploads/2012/12/1-Syringe-Siliconisation-Trends-Methods-Analysis-Procedures.pdf

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026